GlowDx is developing the Worlds First True Point-of-Care (POC) Diagnostics Platform, aimed at tackling Infectious Disease in Emerging Economies. Our first test detects mosquito-bourne infections (Dengue Fever, Chikungunya & Zika Virus), while our AI utilizes machine learning to model & predict future outbreaks.
Looking for a particular GlowDx employee's phone or email?
The GlowDx annual revenue was $373000 in 2026.
Ventas de México is the Director of GlowDx.
17 people are employed at GlowDx.
GlowDx is based in Midleton, Munster.
The NAICS codes for GlowDx are [6215, 62151, 621, 62].
The SIC codes for GlowDx are [80, 807].